2,2-Dimethylpropyl(trimethyl)azanium

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2,2-Dimethylpropyl(trimethyl)azanium
• 化学式: C8H20N+
• 分子量: 130.25
• InChiKey: DXOCDYAMAATVKX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

文献信息

• AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE
  申请人：Shen Jianhua

  公开号：US20140171431A1

  公开（公告）日：2014-06-19

  The present invention relates to the field of pharmaceutical chemistry, and in particular, to a novel class of azole compounds represented by general formula (I), (II) or (III) and a preparation method thereof, a pharmaceutical composition with the compounds as active components, and a use of the azole compounds and the pharmaceutical composition in the preparation of a medicament for treatment of diseases associated with Lp-PLA 2 enzyme activities, wherein each substituent is as defined in the specification.

  本发明涉及制药化学领域，特别是一种由通式（I）、（II）或（III）表示的新型类唑化合物，以及其制备方法，以这些化合物为活性成分的药物组合物，以及在制备用于治疗与Lp-PLA2酶活性相关疾病的药物中使用这些唑化合物和药物组合物的用途，其中每个取代基如规范中定义。
• ORGANIC SYNTHESIS APPLICATIONS OF NON-AQUEOUS FLUORIDE SALT SOLUTIONS
  申请人：CALIFORNIA INSTITUTE OF TECHNOLOGY

  公开号：US20170057908A1

  公开（公告）日：2017-03-02

  Processes and reaction mixtures including non-aqueous solvent mixtures are presented. Non-aqueous solvent mixtures including fluoride salt and non-aqueous solvent combinations are provided that possess high fluoride ion concentrations useful for a range of applications, including organic synthesis. Further non-aqueous solvent mixtures are provided including a salt possessing a non-fluoride anion and a non-aqueous solvent that, when contacted with aqueous fluoride-containing reagents, extract fluoride ions to form non-aqueous fluoride-ion solutions possessing high fluoride-ion concentrations. The salts include an organic cation that does not possess a carbon in the β-position or does not possess a carbon in the β-position having a bound hydrogen. This salt structure facilitates its ability to be made anhydrous without decomposition. Example anhydrous fluoride salts include (2,2-dimethylpropyl)trimethylammonium fluoride and bis(2,2-dimethylpropyl)dimethylammonium fluoride. The combination of these fluoride salts with at least one fluorine-containing non-aqueous solvent (e.g., bis(2,2,2-trifluoroethyl)ether; (BTFE)) promotes solubility of the salt within the non-aqueous solvents.

  提供了包括非水溶剂混合物的过程和反应混合物。提供了包括氟化物盐和非水溶剂组合的非水溶剂混合物，其具有高氟离子浓度，可用于一系列应用，包括有机合成。还提供了包括具有非氟离子的盐和非水溶剂的非水溶剂混合物，当与含氟化物的水溶试剂接触时，提取氟离子以形成具有高氟离子浓度的非水溶性氟离子溶液。这些盐包括一个有机阳离子，该阳离子在β位不含碳或在β位含有结合氢的碳。这种盐的结构有助于使其在无水条件下不分解。例如，无水氟化物盐包括(2,2-二甲基丙基)三甲基铵氟化物和双(2,2-二甲基丙基)二甲基铵氟化物。这些氟化物盐与至少一种含氟非水溶剂（例如双(2,2,2-三氟乙基)醚；(BTFE)）的组合促进了盐在非水溶剂中的溶解度。
• INDOLINE DERIVATIVES SUBSTITUTED IN THE 6 POSITION, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
  申请人：Roth Juergen Gerald

  公开号：US20070004757A1

  公开（公告）日：2007-01-04

  The present invention relates to indolinone derivatives, substituted in the 6-position, of the formula in which R 1 to R 6 and X are as defined in Claim 1 , to their tautomers, enantiomers, diastereomers, to their mixtures and to their salts, in particular their physiologically acceptable salts, which have useful pharmacological properties, in particular in inhibiting action on various receptor tyrosine kinases and on the proliferation of endothelial cells and various tumour cells, to medicaments comprising these compounds, to their use and to processes for their preparation.

  本发明涉及6-位取代的吲哚酮衍生物，其化学式为其中R1至R6和X如权利要求1所定义，以及它们的互变异构体、对映异构体、非对映异构体、混合物和盐，特别是其生理上可接受的盐，具有有用的药理学性质，特别是在抑制各种受体酪氨酸激酶和内皮细胞以及各种肿瘤细胞的增殖方面，以及包含这些化合物的药物、它们的用途和制备方法。
• INDOLINONE DERIVATIVES SUBSTITUTED IN THE 6 POSITION, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
  申请人：ROTH Gerald Juergen

  公开号：US20090197876A1

  公开（公告）日：2009-08-06

  The present invention relates to indolinone derivatives, substituted in the 6-position, of the formula in which R 1 to R 6 and X are as defined in Claim 1 , to their tautomers, enantiomers, diastereomers, to their mixtures and to their salts, in particular their physiologically acceptable salts, which have useful pharmacological properties, in particular in inhibiting action on various receptor tyrosine kinases and on the proliferation of endothelial cells and various tumour cells, to medicaments comprising these compounds, to their use and to processes for their preparation.

  本发明涉及6-位取代的吲哚酮衍生物，其化学式如下：其中R1至R6和X如权利要求1所定义，以及它们的互变异构体、对映异构体、非对映异构体、它们的混合物和它们的盐，特别是它们的生理上可接受的盐，具有有用的药理特性，特别是在抑制各种受体酪氨酸激酶和内皮细胞以及各种肿瘤细胞增殖方面，以及包含这些化合物的药物、它们的使用和它们的制备方法。
• Hydrophilic adhesive masses
  申请人：SSP Co., Ltd.

  公开号：EP0965626A1

  公开（公告）日：1999-12-22

  A hydrophilic adhesive mass contains 0.05 to 10 wt.% of a copolymer of an aminoalkyl (meth)acrylate and an alkyl (meth)acrylate. This hydrophilic adhesive mass is excellent in adhesiveness, and especially when combined with a pharmacologically active ingredient, it is suitable for use in providing hydrophilic plasters.

  一种亲水性粘合剂含有 0.05 至 10 wt.%的氨基烷基（甲基）丙烯酸酯和烷基（甲基）丙烯酸酯共聚物。这种亲水性粘合剂具有极佳的粘合性，特别是与药理活性成分结合使用时，可用于提供亲水性膏药。